MELVIN MD SHAROKY
CIK 1182633 · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.75M
Companies
2
Total Filings
78
Lifetime Open-Market Net
-$7.84M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INSM | Director | 252,928 | $97.85 | $24.75M | -$7.64M | 52 | 2026-05-15 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Director | 5,890 | — | — | -$203.1K | 25 | 2012-07-05 |
Recent Filings · Page 2 of 8
78 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-15 | INSM | Gift (G) | — | $0 | EDGAR |
| 2025-02-27 | INSM | Gift (G) | — | $0 | EDGAR |
| 2024-09-03 | INSM | Gift (G) | — | $0 | EDGAR |
| 2024-05-15 | INSM | Grant (A) | +13,162 | $0 | EDGAR |
| 2024-02-29 | INSM | Gift (G) | — | $0 | EDGAR |
| 2023-05-17 | INSM | Buy (P) | +20,000 | $385.8K | EDGAR |
| 2023-05-15 | INSM | Mixed | +11,392 | $0 | EDGAR |
| 2023-03-17 | INSM | Gift (G) | −3,798 | $0 | EDGAR |
| 2022-11-02 | INSM | Buy (P) | +30,000 | $527.6K | EDGAR |
| 2022-05-13 | INSM | Mixed | +34,645 | $344.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.